Loading...
DA32 Life Science Tech Acquisition Corp.
DALS•NASDAQ
Financial ServicesShell Companies
$10.30
$-0.02(-0.19%)
DA32 Life Science Tech Acquisition Corp. (DALS) Stock Overview
Explore DA32 Life Science Tech Acquisition Corp.’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for DALSStats details for DALS are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for DALSAnalyst Recommendations details for DALS are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business combination targets in the biotechnology and life science infrastructure sectors. DA32 Life Science Tech Acquisition Corp. was incorporated in 2021 and is based in New York, New York.
CEO
Dr. Steven Kafka Ph.D.
Headquarters
345 Park Avenue South, New York, NY
Founded
2021